Document:

Exhibit 4.1

 

AMENDMENT NO. 5 TO RIGHTS AGREEMENT

 

AMENDMENT NO. 5 (this “Amendment”), dated as of November 29, 2018, to the Rights Agreement (the “Rights Agreement”), dated as of December 2, 2015 (as amended by Amendment No. 1 thereto dated as of November 28, 2016, Amendment No. 2 thereto dated as of November 29, 2017, Amendment No. 3 thereto dated as of March 26, 2018 and Amendment No. 4 thereto dated as of May 29, 2018), by and between iKang Healthcare Group, Inc., a company incorporated under the laws of the Cayman Islands (the “Company”), and American Stock Transfer & Trust Company, L.L.C., a New York limited liability trust company, as Rights Agent (the “Rights Agent”). All capitalized terms used but not defined in this Amendment shall have the meanings ascribed to such terms in the Rights Agreement.

 

WHEREAS, the Board of Directors desires to amend the Rights Agreement to extend the Expiration Time;

 

WHEREAS, pursuant to Section 5.4 of the Rights Agreement, the Company, with the approval or at the direction of the Special Committee, and the Rights Agent may, from time to time, supplement or amend the Rights Agreement in any respect prior to the Flip-In Date;

 

WHEREAS, the Flip-In Date has not occurred;

 

WHEREAS, the Special Committee has approved this Amendment; and

 

WHEREAS, pursuant to Section 5.4 of the Rights Agreement, the Company has delivered to the Rights Agent a certificate signed by Daqing Qi, an appropriate officer of the Company, certifying that this Amendment complies with the terms of the Rights Agreement.

 

NOW THEREFORE, in consideration of the foregoing and the mutual agreements set forth herein, the parties agree as follows:

 

1.                                      Amendment of the Rights Agreement. The definition of “Expiration Time” in Section 1.1 of the Rights Agreement is hereby amended and restated in its entirety as follows:

 

“Expiration Time” shall mean the earliest of (i) the Exchange Time, (ii) the Redemption Time, (iii) the Close of Business on December 2, 2019, unless, for purposes of this clause (iii), extended by action of the Board of Directors (in which case the applicable time shall be the time to which it has been so extended), and (iv) immediately prior to the Effective Time (as defined in the Merger Agreement), but only if the Effective Time shall occur, of the Merger (as defined in the Merger Agreement).

 

2.                                      Counterparts. This Amendment may be executed in any number of counterparts (including by facsimile, PDF or other electronic means) and each of such counterparts shall for all purposes be deemed an original, and all such counterparts shall together constitute but one and the same instrument.

 

3.                                      Effectiveness. This Amendment shall be deemed effective as of the date first written above. Except as amended hereby, the Rights Agreement shall remain in full force and effect and shall be otherwise unaffected hereby. The execution, delivery and effectiveness of this Amendment shall not, except as expressly provided herein, constitute a waiver or amendment of any provision of the Rights Agreement.

 

[Signature Page Follows]

 

1

 

IN WITNESS WHEREOF, the parties hereto have caused this Amendment to be duly executed as of the date first above written.

 

	
 
    	
IKANG   HEALTHCARE GROUP, INC.
    
	
 
    	
 
    	
 
    
	
 
    	
By:
    	
/s/ Daqing Qi
    
	
 
    	
 
    	
Name: Daqing Qi
    
	
 
    	
 
    	
Title: Director
    
	
 
    	
 
    	
 
    
	
 
    	
AMERICAN   STOCK TRANSFER & TRUST COMPANY, L.L.C., as Rights Agent
    
	
 
    	
 
    	
 
    
	
 
    	
By:
    	
/s/ Michael Nespoli
    
	
 
    	
 
    	
Name: Michael Nespoli
    
	
 
    	
 
    	
Title: Executive Director
    

 

[Signature Page to Amendment No. 5 to Rights Agreement]EX-10.7

 Exhibit 10.7 

MERIDIAN BIOSCIENCE, INC. 

2012 STOCK INCENTIVE PLAN 

RESTRICTED SHARE UNIT AWARD AGREEMENT 

TIME-BASED (U.S. EMPLOYEES) 
 Summary of
Restricted Share Unit Award Grant 
 Meridian Bioscience, Inc., an Ohio corporation (the “Company”), grants to the Grantee
named below, in accordance with the terms of the Meridian Bioscience, Inc. 2012 Stock Incentive Plan (the “Plan”) and this Restricted Share Unit Award Agreement (the “Agreement”), the following number of Restricted Share Units of
the Company (the “Restricted Units”), on the Grant Date set forth below: 
  

			
	Name of Grantee:	  	                                      
                                         
         
		
	Number of Units:	  	                                      
  
		
	Grant Date:	  	November 15, 2018
		
	Vesting Date:	  	November 15, 2021

 Terms of Agreement 

1.    Grant of Restricted Share Unit Awards. Subject to and upon the terms, conditions, and restrictions set
forth in this Agreement and in the Plan, the Company hereby grants to the Grantee as of the Grant Date, the total number of Restricted Units set forth above. The Restricted Units shall be credited in a book entry account established for the Grantee
until payment in accordance with Section 4 hereof. 
 2.    Vesting of Restricted Units. 

(a)    Except as otherwise provided in this Agreement, this grant of Restricted Units shall vest in full on the Vesting
Date above. Prior to the Vesting Date, no portion of the award is vested, except as otherwise provided in Section 2(b) or (c). 

(b)    All of the Restricted Units shall vest in full prior to the Vesting Date upon the occurrence of any of the
following: (i) the Grantee dies while in the employ of the Company; (ii) the Grantee satisfies the requirements for Retirement, including separation from employment with the Company; (iii) the Grantee has a Disability; or
(iv) there is a Change in Control event described in Section 2(g) of the Plan. 
 (c)    The Committee may, in
its sole discretion, accelerate the time at which the Restricted Units become vested and non-forfeitable to a time other than the Vesting Date as provided in Section 2(a) or to a time other than provided
in Section (2)(b)(i), (ii), (iii) or (iv) on such terms and conditions as it deems appropriate in accordance with the terms and conditions of the Plan, provided such acceleration does not result in an impermissible acceleration of payments
under Section 409A of the Code. 

 3.    Forfeiture of Restricted Units. 

(a)    The Restricted Units that have not yet vested pursuant to Section 2 shall be forfeited automatically without
further action or notice if the Grantee ceases to be employed by the Company other than as provided in Section 2(b) or (c) hereof. 

(b)    The Grantee hereby acknowledges that in order for the Restricted Units to vest, Grantee must, prior to the first
Vesting Date identified on the first page hereof under “Summary of Restricted Share Unit Award Grant”, (i) accept the Restricted Units online or by telephone in accordance with the procedures established by the Company and Merrill Lynch,
and; (ii) open a Merrill Lynch brokerage account through the system maintained on behalf of the Company. If the Grantee has not completed both of the tasks prior to the first Vesting Date identified on the first page hereof under “Summary
of Restricted Share Unit Award Grant”, the Restricted Units shall be forfeited as of such date. 

4.    Payment. 

(a)    Except as otherwise provided in this Agreement, the Company shall deliver to the Grantee one share of its common
stock (“Share”) for each vested Restricted Unit within thirty (30) days following the earlier of: 

(i)    the Vesting Date identified on the first page hereof under “Summary of Restricted Share Unit Award
Grant”; 
 (ii)    the date of the Grantee’s death; 

(iii)    the date of the Grantee’s Disability, provided such Disability also constitutes a “disability”
within the meaning of Section 409A of the Code with respect to a Grantee whose Restricted Units are subject to Section 409A of the Code; 

(iv)    the date of Grantee’s termination of employment with the Company as a result of Retirement or a Change in
Control event described in Section 2(g)(i) or (ii) of the Plan, provided such termination of employment also constitutes a “separation from service” within the meaning of Section 409A of the Code with respect to a Grantee
whose Restricted Units are subject to Section 409A of the Code; or 
 (v)    the date of an event described in
Section 2(g)(iii) or (iv) of the Plan, provided such event also constitutes a “change in control event” within the meaning of Section 409A of the Code with respect to a Grantee whose Restricted Units are subject to
Section 409A of the Code. 
 If the Grantee is a “specified employee” within the meaning of Section 409A of the Code on the date of the
Grantee’s separation from service and the Grantee’s Restricted Units are subject to Section 409A of the Code, then payment under (iv) above shall be made on the first day of the seventh month following the Grantee’s
separation from service, or, if earlier, the date of the Grantee’s death. 
 (b)    The Company’s obligations
with respect to the Restricted Units shall be satisfied in full upon the delivery of its Shares pursuant to Section 4(a) herein. 

5.    Transferability. The Restricted Units may not be transferred and shall not be subject in any manner to
assignment, alienation, pledge, encumbrance or charge, until all restrictions are removed or have expired, unless otherwise provided under the Plan. Any purported Transfer or encumbrance in violation of the provisions of this Section 5 shall be
void, and the other party to any such purported transaction shall not obtain any rights to or interest in such Restricted Units. 

  
 - 2 - 

 6.    Voting and Other Rights. The Grantee will not have
any rights of a shareholder of the Company with respect to the Restricted Units until the delivery of the underlying Shares. The obligations of the Company under this Agreement will be merely that of an unfunded and unsecured promise of the Company
to deliver Shares in the future, and the rights of the Grantee will be no greater than that of an unsecured general creditor. No assets of the Company will be held or set aside as security for the obligations of the Company under this Agreement.

 7.    Dividend Equivalent Payment Rights. The Grantee shall possess dividend equivalent payment rights
with respect to the Restricted Units granted pursuant to this Agreement as of the Grant Date. Any dividend equivalent payment on the Restricted Units shall be based on the number of Restricted Units credited to the Grantee as of the dividend record
date and such credited dividend equivalent payment amount shall be paid in accordance with quarterly dividend declarations by the Board of Directors on the Company’s common stock. 

8.    Continuous Employment. Unless otherwise specified by the Plan, for purposes of this Agreement, the
continuous employment of the Grantee with the Company shall not be deemed to have been interrupted, and the Grantee shall not be deemed to have ceased to be an employee of the Company, by reason of the transfer of his employment among the Company or
a leave of absence approved by the Committee. 
 9.    No Employment Contract. Nothing contained in this
Agreement shall confer upon the Grantee any right with respect to continuance of employment by the Company, nor limit or affect in any manner the right of the Company to terminate the employment or adjust the compensation of the Grantee. 

10.    Relation to Other Benefits. Any economic or other benefit to the Grantee under this Agreement or the
Plan shall not be taken into account in determining any benefits to which the Grantee may be entitled under any profit-sharing, retirement or other benefit or compensation plan maintained by the Company and shall not affect the amount of any life
insurance coverage available to any beneficiary under any life insurance plan covering employees of the Company.  

11.    Taxes and Withholding. To the extent that the Company is required to withhold any federal, state,
local, foreign or other tax in connection with the Restricted Units or dividend equivalent payments thereon pursuant to this Agreement, it shall be a condition to earning the award that the Grantee make arrangements satisfactory to the Company for
payment of such taxes required to be withheld. With respect to payments under Section 4 herein, the Committee may, in its sole discretion, require the Grantee to satisfy such required withholding obligation by surrendering to the Company a
portion of the Shares earned by the Grantee hereunder, and the Shares so surrendered by the Grantee shall be credited against any such withholding obligation at the Fair Market Value of such Shares on the date of surrender. 

12.    Adjustments. The number and kind of Shares deliverable pursuant to a Restricted Unit are subject to
adjustment as provided in Section 8 of the Plan.  
 13.    Compliance with Law.
While the Company shall make reasonable efforts to comply with all applicable federal and state securities laws and listing requirements with respect to the Restricted Units or Shares that may be delivered pursuant to Section 4 herein, the
Company shall not be obligated to deliver any Restricted Units or Shares pursuant to this Agreement if the delivery thereof would result in a violation of any such law or listing requirement. 

14.    Amendments. Subject to the terms of the Plan, the Committee may modify this Agreement upon written
notice to the Grantee. Any amendment to the Plan shall be deemed to be an amendment to this Agreement to the extent that the amendment is applicable hereto; provided, however, no amendment of the Plan or this Agreement shall adversely
affect the rights of the Grantee under this Agreement without the Grantee’s consent unless the Committee determines, in good faith, that such amendment is required for the Agreement to either be exempt from the application of, or comply with,
the requirements of Section 409A of the Code, or as otherwise may be provided in the Plan. 

  
 - 3 - 

 15.    Section 409A of the Code. It is intended that the
Restricted Units shall be exempt from the application of, or comply with, the requirements of Section 409A of the Code. The terms of this Agreement shall be construed, administered, and governed in a manner that effects such intent, and the
Committee shall not take any action that would be inconsistent with such intent. Without limiting the foregoing, the Restricted Units shall not be deferred, accelerated, extended, paid out, settled, adjusted, substituted, exchanged or modified in a
manner that would cause the award to fail to satisfy the conditions of an applicable exception from the requirements of Section 409A of the Code or otherwise would subject the Grantee to the additional tax imposed under Section 409A of the
Code. 
 16.    Severability. In the event that one or more of the provisions of this Agreement shall be
invalidated for any reason by a court of competent jurisdiction, any provision so invalidated shall be deemed to be separable from the other provisions hereof, and the remaining provisions hereof shall continue to be valid and fully enforceable.

 17.    Relation to Plan. This Agreement is subject to the terms and conditions of the Plan. This
Agreement and the Plan contain the entire agreement and understanding of the parties with respect to the subject matter contained in this Agreement, and supersede all prior written or oral communications, representations and negotiations in respect
thereto. In the event of any inconsistency between the provisions of this Agreement and the Plan, the Plan shall govern except with respect to Section 2(a) of this Agreement. Capitalized terms used herein without definition shall have the
meanings assigned to them in the Plan. The Committee acting pursuant to the Plan, as constituted from time to time, shall, except as expressly provided otherwise herein, have the right to determine any questions which arise in connection with the
grant of the Restricted Units. 
 18.    Successors and Assigns. Without limiting Section 5, the
provisions of this Agreement shall inure to the benefit of, and be binding upon, the successors, administrators, heirs, legal representatives and assigns of the Grantee, and the successors and assigns of the Company. 

19.    No Advice Regarding Award. The Company is not providing any tax, legal or financial
advice, nor is the Company making any recommendations regarding the Grantee’s participation in the Plan or the acquisition or sale of the underlying securities. The Grantee is hereby advised to consult with the Grantee’s personal tax,
legal or financial advisors regarding the decision to participate in the Plan before taking any action related to the Plan. 

20.    Governing Law. 

(a)    The interpretation, performance, and enforcement of this Agreement, including tort claims, shall be governed by the
laws of the State of Ohio, without giving effect to the principles of conflict of laws thereof. 
 (b)    Any party
bringing a legal action or proceeding against another party arising out of or relating to this Agreement may bring the legal action or proceeding only in the United States District Court for the Southern District of Ohio and any of the courts of the
State of Ohio, in each case sitting in Cincinnati, Ohio. 
 (c)    Each of the Company and the Grantee waives, to the
fullest extent permitted by law, (i) any objection which it may now or later have to the laying of venue of any legal action or proceeding arising out of or relating to this Agreement brought in any court of the State of Ohio sitting in
Cincinnati, Ohio or the United States District Court for the Southern District of Ohio sitting in Cincinnati, Ohio, including, without limitation, a motion to dismiss on the grounds of forum non conveniens or lack of subject matter
jurisdiction; and (ii) any claim that any action or proceeding brought in any such court has been brought in an inconvenient forum. 

  
 - 4 - 

 (d)    Each of the Company and the Grantee submits to the exclusive
jurisdiction (both personal and subject matter) of (i) the United States District Court for the Southern District of Ohio sitting in Cincinnati, Ohio and its appellate courts, and (ii) any court of the State of Ohio sitting in Cincinnati,
Ohio and its appellate courts, for the purposes of all legal actions and proceedings arising out of or related to this Agreement. 

21.    Language. If the Grantee receives this Agreement or any other document related to the Plan translated
into a language other than English and if the meaning of the translated version is different than the English version, the English version will control. 

22.    Electronic Delivery. The Grantee hereby consents and agrees to electronic delivery of any documents
that the Company may elect to deliver (including, but not limited to, prospectuses, prospectus supplements, grant or award notifications and agreements, account statements, annual and quarterly reports, and all other forms of communications) in
connection with this and any other award made or offered under the Plan. The Grantee understands that, unless earlier revoked by the Grantee by giving written notice to the Secretary of the Company, this consent shall be effective for the duration
of the Agreement. The Grantee also understands that he or she shall have the right at any time to request that the Company deliver written copies of any and all materials referred to above at no charge. The Grantee hereby consents to any and all
procedures the Company has established or may establish for an electronic signature system for delivery and acceptance of any such documents that the Company may elect to deliver, and agrees that his or her electronic signature is the same as, and
shall have the same force and effect as, his or her manual signature. The Grantee consents and agrees that any such procedures and delivery may be effected by a third party engaged by the Company to provide administrative services related to the
Plan. 
 IN WITNESS WHEREOF, the Company has caused this Agreement to be executed on its behalf by its duly authorized officer and the
Grantee has also executed this Agreement, as of the Grant Date. 
  

			
	MERIDIAN BIOSCIENCE, INC.
		
	By:	 	  

	Name:	 	Bryan T. Baldasare
	Title:	 	Sr. Vice President, Corporate Controller and Treasurer

  
 - 5 -

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00289-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00289-of-00352.parquet"}]]